Opportunity overview
DHSC is conducting market engagement to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of take-home naloxone that can reverse the effect of an opioid overdose. In particular, we are looking to understand how these suppliers and manufacturers could potentially meet the future of needs of a UK Buffer Stock of Naloxone. This is not a call for competition, but an opportunity to gather feedback via a questionnaire to better understand market capabilities, and encourage supplier engagement. Interested parties can access the relevant documents via the Atamis system at https://health-family.force.com/s/Welcome using the contract reference, you may also submit the completed questionnaire through Atamis but must be registered on the system to do so. Alternatively, submit questionnaires to ccsinbox@dhsc.gov.uk
Classification
- CPV33600000 — Pharmaceutical products
- CPV33670000 — Medicinal products for the respiratory system
- CPV33693300 — Addiction treatment
Lots
- Lot 1Value not stated
Documents and notices
- Procurement termination notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗